This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


Plasminogen activator

From Proteopedia

Revision as of 10:36, 4 July 2016 by Michal Harel (Talk | contribs)
Jump to: navigation, search

Template:STRUCTURE 1a5h

Plasminogen activator (PLA) is a serine protease which converts plasminogen to plasmin. TPA structure contains heavy and light chains (HC, LC). PLA is inhibited by PLA inhibitor 1 and 2.

  • Tissue PLA (TPA) which is involved in breakdown of blood clots and urokinase-type PLA Urokinase.

Relevance

Treatment with tissue PLA for acute ischemic stroke is beneficial[1].

3D structures of plasminogen activator

Updated on 04-July-2016


References

  1. ↑ . Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995 Dec 14;333(24):1581-7. PMID:7477192 doi:http://dx.doi.org/10.1056/NEJM199512143332401

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky, Joel L. Sussman

Retrieved from "http://52.214.119.220/wiki/index.php/Plasminogen_activator"
Personal tools